1. Home
  2. HALO vs G Comparison

HALO vs G Comparison

Compare HALO & G Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$63.67

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Logo Genpact Limited

G

Genpact Limited

HOLD

Current Price

$38.40

Market Cap

7.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
HALO
G
Founded
1998
1997
Country
United States
Bermuda
Employees
N/A
140000
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
7.2B
IPO Year
2001
2007

Fundamental Metrics

Financial Performance
Metric
HALO
G
Price
$63.67
$38.40
Analyst Decision
Buy
Buy
Analyst Count
11
6
Target Price
$78.18
$49.50
AVG Volume (30 Days)
1.8M
2.1M
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
1.97%
EPS Growth
N/A
9.82
EPS
2.56
3.13
Revenue
$151,862,000.00
$2,279,438,000.00
Revenue This Year
$28.24
$9.23
Revenue Next Year
$12.79
$7.26
P/E Ratio
$24.83
$12.22
Revenue Growth
N/A
N/A
52 Week Low
$47.50
$34.79
52 Week High
$82.22
$51.28

Technical Indicators

Market Signals
Indicator
HALO
G
Relative Strength Index (RSI) 28.72 40.68
Support Level $61.23 $37.58
Resistance Level $65.40 $46.04
Average True Range (ATR) 1.87 1.08
MACD -0.73 0.07
Stochastic Oscillator 5.17 28.41

Price Performance

Historical Comparison
HALO
G

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About G Genpact Limited

Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.

Share on Social Networks: